Physician profile
Derek Mello
NPI 1366824054
$2,606.40
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,675 · 2022: $904 · 2023: $27.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $27.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $27.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $665.07 | 2021-2022 | |
| Nevro Corp. | $522.92 | 2021-2023 | Senza |
| Nalu Medical, INC. | $212.41 | 2021 | |
| Abbvie INC. | $208.27 | 2021-2022 | |
| Spr Therapeutics, INC | $164.92 | 2021 | |
| Pacira Therapeutics, INC. | $114.85 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $103.82 | 2021 | |
| Scilex Pharmaceuticals INC. | $94.58 | 2021 | |
| Alfasigma USA, INC. | $71.75 | 2021-2022 | |
| Almatica Pharma LLC | $71.64 | 2021 | |
| Collegium Pharmaceutical, INC. | $71.40 | 2021-2022 | |
| Eisai INC. | $49.93 | 2021-2022 | |
| Amgen INC. | $49.16 | 2021-2022 | |
| Hikma Pharmaceuticals USA | $39.82 | 2022 | |
| Bioventus LLC | $34.02 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $26.60 | 2022 | |
| Redhill Biopharma INC. | $23.84 | 2021 | |
| Grt US Holding, INC. | $22.94 | 2021 | |
| Biodelivery Sciences International, INC. | $17.54 | 2021 | |
| Otto Bock Healthcare LP | $14.48 | 2022 | |
| Smith+Nephew, INC. | $13.97 | 2021 | |
| Uswm, LLC | $12.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Mello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.